Cargando…

Anti-Apoptotic c-FLIP Reduces the Anti-Tumour Activity of Chimeric Antigen Receptor T Cells

SIMPLE SUMMARY: Chimeric antigen receptor (CAR) T cell treatment is a promising adoptive cell therapy that utilises CAR-expressing primary T cells to target specific tumour antigens. Since its first approval in 2017, the FDA has approved six CAR T cell therapies for blood cancer treatment. Despite t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Grace Min Yi, Poudel, Aarati, Ali Hosseini Rad, Seyed Mohammad, McLellan, Alexander Donald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564159/ https://www.ncbi.nlm.nih.gov/pubmed/36230780 http://dx.doi.org/10.3390/cancers14194854

Ejemplares similares

Optimisation of Tet-On inducible systems for Sleeping Beauty-based chimeric antigen receptor (CAR) applications
por: Ali Hosseini Rad, S. M., et al.
Publicado: (2020)

Promoter choice: Who should drive the CAR in T cells?
por: Rad S. M., Ali Hosseini, et al.
Publicado: (2020)

Compact Bidirectional Promoters for Dual-Gene Expression in a Sleeping Beauty Transposon
por: He, Kevin, et al.
Publicado: (2020)

MicroRNA‐mediated metabolic reprogramming of chimeric antigen receptor T cells
por: Rad, Seyed Mohammad Ali Hosseini, et al.
Publicado: (2022)

Metabolic and Mitochondrial Functioning in Chimeric Antigen Receptor (CAR)—T Cells
por: Rad S. M., Ali Hosseini, et al.
Publicado: (2021)

Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy
por: Safa, Ahmad R., et al.
Publicado: (2011)

Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations
por: Weinkove, Robert, et al.
Publicado: (2019)

Apoptotic mitochondria prime anti-tumour immunity
por: McArthur, Kate, et al.
Publicado: (2020)

Vicrostatin – An Anti-Invasive Multi-Integrin Targeting Chimeric Disintegrin with Tumor Anti-Angiogenic and Pro-Apoptotic Activities
por: Minea, Radu O., et al.
Publicado: (2010)

FLIP as an Anti-Cancer Therapeutic Target
por: Yang, Jin Kuk
Publicado: (2008)

Tumor-Derived Apoptotic Vesicles: With Death They Do Part
por: Muhsin-Sharafaldine, Morad-Remy, et al.
Publicado: (2018)

Implications of SARS-CoV-2 Mutations for Genomic RNA Structure and Host microRNA Targeting
por: Hosseini Rad SM, Ali, et al.
Publicado: (2020)

The retinoblastoma protein (Rb) as an anti-apoptotic factor: expression of Rb is required for the anti-apoptotic function of BAG-1 protein in colorectal tumour cells
por: Collard, T J, et al.
Publicado: (2012)

Flipping the dogma – phosphatidylserine in non-apoptotic cell death
por: Shlomovitz, Inbar, et al.
Publicado: (2019)

Development and Characterization of Chimeric Anti‐carcinoembryonic Antigen Monoclonal Antibodies and Their Fab Fragments
por: Kamigaki, Takashi, et al.
Publicado: (1994)

Chimeric antigen receptors: unleashing a new age of anti-cancer therapy
por: Leyfman, Yan
Publicado: (2018)

Efficacy of anti-CD147 chimeric antigen receptors targeting hepatocellular carcinoma
por: Tseng, Hsiang-chi, et al.
Publicado: (2020)

Engineering chimeric antigen receptor T cells for solid tumour therapy
por: Liu, Longwei, et al.
Publicado: (2022)

A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors
por: De Oliveira, Satiro N, et al.
Publicado: (2013)

Anti-Apoptotic Effects of Resistance Training and Tribulus Terrestris Consumption in the Heart Tissue of Rats Exposed to Stanozolol
por: Arjmand, Ayat, et al.
Publicado: (2021)

Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains
por: Lam, Norris, et al.
Publicado: (2020)

FLIP regulation of HO-1 and TNF signalling in human acute myeloid leukemia provides a unique secondary anti-apoptotic mechanism
por: Rushworth, Stuart A, et al.
Publicado: (2010)

Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells
por: An, Na, et al.
Publicado: (2016)

Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor
por: Zhang, Ge, et al.
Publicado: (2014)

Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies
por: Chen, Kevin H., et al.
Publicado: (2016)

Anti-mucin 1 chimeric antigen receptor T cells for adoptive T cell therapy of cholangiocarcinoma
por: Supimon, Kamonlapat, et al.
Publicado: (2021)

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens
por: thor Straten, Per, et al.
Publicado: (2010)

Pattern variation is linked to anti-predator coloration in butterfly larvae
por: McLellan, Callum F., et al.
Publicado: (2023)

Chimeric antigen receptor macrophage therapy for breast tumours mediated by targeting the tumour extracellular matrix
por: Zhang, Wenlong, et al.
Publicado: (2019)

Noise-Reduction and Sensitivity-Enhancement of a Sleeping Beauty-Based Tet-On System
por: Saunderson, Sarah C., et al.
Publicado: (2022)

Tumor regression and immunity in combination therapy with anti-CEA chimeric antigen receptor T cells and anti-CEA-IL2 immunocytokine
por: Cha, Seung E., et al.
Publicado: (2021)

The Anti-Apoptotic Role of Neurotensin
por: Devader, Christelle, et al.
Publicado: (2013)

The Anti-Apoptotic Role of Neuroglobin
por: Brittain, Thomas
Publicado: (2012)

Development of a monoclonal antibody for the detection of anti-canine CD20 chimeric antigen receptor expression on canine CD20 chimeric antigen receptor-transduced T cells
por: SAKAI, Osamu, et al.
Publicado: (2021)

Preclinical targeting of aggressive T-cell malignancies using anti-CD5 chimeric antigen receptor
por: Chen, K H, et al.
Publicado: (2017)

Anti-CD19 chimeric antigen receptor targeting of CD19 + acute myeloid leukemia
por: Ma, Gina, et al.
Publicado: (2018)

Anti-EGFRvIII Chimeric Antigen Receptor-Modified T Cells for Adoptive Cell Therapy of Glioblastoma
por: Ren, Pei-pei, et al.
Publicado: (2017)

Enhancing Chimeric Antigen Receptor T Cell Anti-tumor Function through Advanced Media Design
por: Ghassemi, Saba, et al.
Publicado: (2020)

CXCR5 guides migration and tumor eradication of anti-EGFR chimeric antigen receptor T cells
por: Li, Guangchao, et al.
Publicado: (2021)

Immune inactivation of anti-simian immunodeficiency virus chimeric antigen receptor T cells in rhesus macaques
por: Haeseleer, Françoise, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h52glts5s869ct4ip6gdeo1bnn